The state of South Dakota currently has 1 active clinical trials seeking participants for Alzheimer's Disease research studies. These trials are conducted in various cities, including Sioux Falls, Rapid City, Aberdeen and Watertown.
A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)
Recruiting
The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD). Approximately 800 additional participants will be enrolled in a 12-month addendum to assess safety of a different titration regimen.
Gender:
ALL
Ages:
Between 65 years and 80 years
Trial Updated:
06/24/2025
Locations: Health Concepts, Rapid City, South Dakota
Conditions: Alzheimer Disease